Terms: = Head and neck cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
6802 results:
1. Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation.
Wils LJ; Buijze M; Stigter-van Walsum M; Brink A; van Kempen BE; Peferoen L; Brouns ER; de Visscher JGAM; van der Meij EH; Bloemena E; Poell JB; Brakenhoff RH
Cells; 2024 Apr; 13(8):. PubMed ID: 38667326
[TBL] [Abstract] [Full Text] [Related]
2. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
[TBL] [Abstract] [Full Text] [Related]
3. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
[TBL] [Abstract] [Full Text] [Related]
5. Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function.
Takahashi J; Suzuki T; Sato M; Nitta S; Yaguchi N; Muta T; Tsuchida K; Suda H; Morita M; Hamada S; Masamune A; Takahashi S; Kamei T; Yamamoto M
Cell Rep; 2024 Apr; 43(4):114104. PubMed ID: 38602872
[TBL] [Abstract] [Full Text] [Related]
6. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
[TBL] [Abstract] [Full Text] [Related]
7. Overcoming data scarcity in radiomics/radiogenomics using synthetic radiomic features.
Ahmadian M; Bodalal Z; van der Hulst HJ; Vens C; Karssemakers LHE; Bogveradze N; Castagnoli F; Landolfi F; Hong EK; Gennaro N; Pizzi AD; Beets-Tan RGH; van den Brekel MWM; Castelijns JA
Comput Biol Med; 2024 May; 174():108389. PubMed ID: 38593640
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract] [Full Text] [Related]
9. Survival benefits of human papillomavirus 16 infection in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy: A retrospective cohort study.
Qu F; Ji C; Wang Y; Zhu R; Hu W; Liu S; Zhao X; Li J; Miao G; Zhang M; Zhang X; Sun Y
J Med Virol; 2024 Apr; 96(4):e29592. PubMed ID: 38587184
[TBL] [Abstract] [Full Text] [Related]
10. Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells.
Islam A; Chang YC; Chen XC; Weng CW; Chen CY; Wang CW; Chen MK; Tikhomirov AS; Shchekotikhin AE; Chueh PJ
Elife; 2024 Apr; 12():. PubMed ID: 38567911
[TBL] [Abstract] [Full Text] [Related]
11. p53-associated miRNAs repress lncRNA ZFAS1 to retard the proliferation of papillary thyroid carcinoma.
Wang G; Wei L; Yang H
Endokrynol Pol; 2024; 75(1):12-19. PubMed ID: 38497385
[TBL] [Abstract] [Full Text] [Related]
12. MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
Huang J; Fehr A; Jäwert F; Nilsson JA; Morris LGT; Stenman G; Andersson MK
Oral Oncol; 2024 Apr; 151():106763. PubMed ID: 38493544
[TBL] [Abstract] [Full Text] [Related]
13. Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
Guan Z; Liu J; Zheng L
Sci Rep; 2024 Mar; 14(1):6304. PubMed ID: 38491080
[TBL] [Abstract] [Full Text] [Related]
14. Multifunctional curcumin mediated zinc oxide nanoparticle enhancing biofilm inhibition and targeting apoptotic specific pathway in oral squamous carcinoma cells.
Tayyeb JZ; Priya M; Guru A; Kishore Kumar MS; Giri J; Garg A; Agrawal R; Mat KB; Arockiaraj J
Mol Biol Rep; 2024 Mar; 51(1):423. PubMed ID: 38489102
[TBL] [Abstract] [Full Text] [Related]
15. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract] [Full Text] [Related]
16. High incidence of HPV infection in minors with oral squamous cell carcinoma.
Wu N; Li Y; Ma X; Huang Z; Chen Z; Chen W; Zhang R
Diagn Pathol; 2024 Mar; 19(1):51. PubMed ID: 38461286
[TBL] [Abstract] [Full Text] [Related]
17. Genoprotective role of pembrolizumab liposome in isolated lymphocytes from head and neck squamous cell carcinoma patients compared to those from healthy individuals
Bobtina N; Alhawamdeh M; Habas K; Isreb M; Aburas B; Harris AT; Najafzadeh M; Anderson D
Nanotoxicology; 2024 Feb; 18(1):55-68. PubMed ID: 38449434
[TBL] [Abstract] [Full Text] [Related]
18. Triggering receptor expressed in myeloid cells 1 (TREM1) as a potential prognostic biomarker and association with immune infiltration in oral squamous cell carcinoma.
Kannan B; Pandi C; Pandi A; Jayaseelan VP; Arumugam P
Arch Oral Biol; 2024 May; 161():105926. PubMed ID: 38442472
[TBL] [Abstract] [Full Text] [Related]
19. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study.
Zheng J; Wang T; Yang Y; Huang J; Feng J; Zhuang W; Chen J; Zhao J; Zhong W; Zhao Y; Zhang Y; Song Y; Hu Y; Yu Z; Gong Y; Chen Y; Ye F; Zhang S; Cao L; Fan Y; Wu G; Guo Y; Zhou C; Ma K; Fang J; Feng W; Liu Y; Zheng Z; Li G; Wang H; Cang S; Wu N; Song W; Liu X; Zhao S; Ding L; Selvaggi G; Wang Y; Xiao S; Wang Q; Shen Z; Zhou J; Zhou J; Zhang L
Cancer Commun (Lond); 2024 Apr; 44(4):455-468. PubMed ID: 38421881
[TBL] [Abstract] [Full Text] [Related]
20. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma.
Khan S; Alamgir MM
J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239
[TBL] [Abstract] [Full Text] [Related]
[Next]
